Posted by jrbecker76 on January 21, 2009, at 19:05:16
In reply to Re: Desipramine vs Strattera for adult ADD., posted by SLS on January 21, 2009, at 6:59:23
as an aside, i find it interesting that eli lilly is putting their money on a "second generation" norepinephrine reuptake inhibitor (LY 2216684) to eventually replace both Straterra for ADHD and Cymbalta for depression. The mechanism of noradrenergic reuptake inhibition for either depression or adhd indications has proven to be less than impressive though, so I'm curious to see just how much more efficacious a new compound can elevate itself above reboxetine or atomoxetine.
poster:jrbecker76
thread:875152
URL: http://www.dr-bob.org/babble/20090104/msgs/875344.html